FDA Green-Lights First CAR-T Cancer Drug
The leukemia treatment approval opens up a new front for gene therapies in the U.S.
The leukemia treatment approval opens up a new front for gene therapies in the U.S.
In an excerpt from his new book, an MIT physicist explores the next stage of human evolution
Correcting gait early on may aid mobility
Computer-security methods could help scientists identify disease-causing genes—while preserving patient privacy
Researchers are using 3-D modeling to identify the future’s heartiest pickings
Unfortunately, the biggest recipients of government help are the pharmaceutical companies, not patients
Sometimes they find they are not as “white” as they’d hoped
Sophisticated software could help doctors make better diagnoses
The Human Dx platform aims to improve the accuracy of individual physicians
CRISPR has enabled researchers to inactivate viruses in donor animals that may sicken humans
Artificially intelligent machines could analyze huge databases to find potential targets for the devastating disease
A treatment aims to reverse long-term scar-tissue damage
European regulators have approved two such treatments
US firm AquaBounty Technologies says that its transgenic fish has hit the market after a 25-year wait
A transport vehicle the size of a virus may ferry chemotherapies and other molecular cargo through the imposing blood–brain barrier
The findings hint at treatments that could restore the balance of brain activity
Scientists have edited a human embryo, but we’re not in scary scifi territory by a long shot
American researchers publish highly anticipated study using CRISPR in developing humans
New “expansion pathology” technique lets optical microscopes go where only electrons could go before
Reports suggest researchers have altered DNA and made few errors
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account